San Raffaele
Targeted therapy in Italy costs from $20,000 to $40,000 on average. Prices change based on the drug type, cancer stage, and city. In the US, similar procedures cost around $40,000 on average. Patients can find savings of around 25% compared to US prices. The cost usually includes the initial oncologist consultation and the medication administration.
Bookimed Expert Insight: Milan serves as Italy's primary hub for oncology. San Raffaele Hospital acts as a major research center. It is accredited by the Italian Ministry of Health (IRCCS). They pioneered the world's first stem cell therapy for ADA-SCID. Choosing Milan-based centers provides access to clinical trials. These trials can significantly reduce out-of-pocket costs for advanced therapies.
Why choose Italy for targeted therapy?
Access advanced Targeted therapy solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Targeted therapy | from $20,000 | from $1,000 | from $12,000 |
| Lutetium-177 therapy | from $8,500 | from $8,800 | from $35,000 |
| Actinium-225 Therapy | from $45,000 | from $22,955 | from $55,000 |
| Oncothermia | from $2,400 | from $450 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
The doctor is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. The doctor is a Principal Investigator in Cell and Gene Therapy clinical trials for hematological cancers, immune-deficiencies, and neuromuscular disorders.
Since 2001, the doctor has served as a medical director at the Hematology Division of the Bone Marrow Transplantation and Transfusion Medicine in IRCCS San Raffaele Hospital. The doctor has published over 180 papers and holds a Merit Recognition Award from the University of Ferrara.
The doctor is a member of numerous prestigious organizations, including the European Hematology Association and the International Network for Cancer Research Trial.
Written by Anna Shchur
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.